Receptor activator of nuclear factor‐κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Hepatology

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.24756PMID 22031462PMCID PMC3276725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CXC chemokines play a critical role in liver injury, recovery, and regeneration.

  2009cited by this paper
• The peptidyl-prolyl isomerase, Pin1, facilitates NF-kappaB binding in hepatocytes and protects against hepatic ischemia/reperfusion injury.

  2009cited by this paper
• Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.

  2009cited by this paper
• Roles of nuclear factor‐κB in postischemic liver

  2008cited by this paper
• Roles of nuclear factor-kappaB in postischemic liver.

  2008cited by this paper
• Hepatocyte NF-kappaB activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia.

  2007influential reference
• Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions.

  2006cited by this paper
• B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.

  2006cited by this paper
• Osteoprotegerin and receptor activator of nuclear factor‐κB ligand system in the early post‐operative period of liver transplantation

  2006cited by this paper
• Potential role for IL-23 in hepatic ischemia/reperfusion injury

  2006cited by this paper
• Intracellular survival pathways in the liver

  2006cited by this paper
• Roles for NF-κB in nerve cell survival, plasticity, and disease

  2006cited by this paper
• Roles for NF-kappaB in nerve cell survival, plasticity, and disease.

  2006cited by this paper
• IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss

  2005cited by this paper
• AGE-DEPENDENT RESPONSES TO HEPATIC ISCHEMIA/REPERFUSION INJURY

  2005influential reference
• Cytokine Cascades and the Hepatic Inflammatory Response to Ischemia and Reperfusion

  2003cited by this paper
• High serum osteoprotegerin and low RANKL in primary biliary cirrhosis.

  2003cited by this paper
• Transgenic mice overexpressing human Bcl-2 are resistant to hepatic ischemia and reperfusion.

  2002cited by this paper
• Receptor Activator of NF-κB and Osteoprotegerin Expression by Human Microvascular Endothelial Cells, Regulation by Inflammatory Cytokines, and Role in Human Osteoclastogenesis*

  2001cited by this paper
• Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.

  2000cited by this paper
• Requirement for interleukin‐12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice

  1999cited by this paper
• Reduction of ischemia-reperfusion injury of the liver by in vivo adenovirus-mediated gene transfer of the antiapoptotic Bcl-2 gene.

  1999cited by this paper
• Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein‐2 and KC

  1998cited by this paper
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis.

  1998cited by this paper
• Bcl-2 regulates nonapoptotic signal transduction: inhibition of c-Jun N-terminal kinase (JNK) activation by IL-1 beta and hydrogen peroxide.

  1998cited by this paper
• Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein‐2 and kupffer cells

  1998cited by this paper
• Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

  1998cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

  1997cited by this paper
• Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation.

  1996cited by this paper
• Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury.

  1994cited by this paper
• A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues.

  1994cited by this paper
• Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver.

  1991cited by this paper
• Reactive oxygen and ischemia/reperfusion injury of the liver.

  1991cited by this paper
• Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

  1990cited by this paper
• Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity.

  1990cited by this paper

• Incomplete elimination of viral genomes is associated with chronic inflammation in nonhuman primate livers after AAV-mediated gene transfer

  2025cites this paper
• Exosomal miR-216a-5p targeting TLR-4 alleviates liver ischemia-reperfusion injury by regulating M2 macrophage polarization and neutrophil inflammation

  2025cites this paper
• Mitochondrial Transplantation Reduces Injury and Improves Liver Function in a Porcine Model of Hemi-Hepatic Ischemia/reperfusion.

  2025cites this paper
• Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets

  2024cites this paper
• Modulation of the hepatic RANK-RANKL-OPG axis by combined C5 and CD14 inhibition in a long-term polytrauma model

  2024cites this paper
• Von Hippel-Lindau deficiency protects the liver against ischemia/reperfusion injury through the regulation of hypoxia-inducible factor 1α and 2α

  2024cites this paper
• TDO2 deficiency attenuates the hepatic lipid deposition and liver fibrosis in mice with diet-induced non-alcoholic fatty liver disease

  2023cites this paper
• Delayed denervation-induced muscle atrophy in Opg knockout mice

  2023cites this paper
• Hepatic Ischemia-Reperfusion Injury: Protective Approaches and Treatment.

  2023cites this paper
• Progress and Prospects of Non-Canonical NF-κB Signaling Pathway in the Regulation of Liver Diseases

  2022cites this paper
• Inflammatory response to the ischaemia–reperfusion insult in the liver after major tissue trauma

  2022cites this paper
• Tissue-Specific Hydrogels Ameliorate Hepatic Ischemia/Reperfusion Injury in Rats by Regulating Macrophage Polarization via TLR4/NF-κB Signaling.

  2021cites this paper
• NR4A1 knockdown confers hepatoprotection against ischaemia‐reperfusion injury by suppressing TGFβ1 via inhibition of CYR61/NF‐κB in mouse hepatocytes

  2021cites this paper
• Transcriptomic Analysis of Rat Macrophages

  2021cites this paper
• Circular RNA Microarray Analyses in Hepatic Ischemia-Reperfusion Injury With Ischemic Preconditioning Prevention

  2021cites this paper
• Inhibiting adipose tissue M1 cytokine expression decreases DPP4 activity and insulin resistance in a type 2 diabetes mellitus mouse model

  2021cites this paper
• Osteoprotegerin Is more than a Possible Serum Marker in Liver Fibrosis: A Study into Its Function in Human and Murine Liver

  2020cites this paper
• An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac

  2020cites this paper
• Supplementation of endogenous Ahr ligands reverses insulin resistance and associated inflammation in an insulin-dependent diabetic mouse model.

  2020cites this paper
• Guanine nucleotide–binding protein G(i)α2 aggravates hepatic ischemia‐reperfusion injury in mice by regulating MLK3 signaling

  2019cites this paper
• Six‐Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia‐Reperfusion Injury by Suppressing Transforming Growth Factor‐β‐Activated Kinase 1

  2019cites this paper
• Comprehensive and combined omics analysis reveals factors of ischemia-reperfusion injury in liver transplantation.

  2019cites this paper
• Protective effects of gastrin‐releasing peptide receptor antagonist RC‐3095 in an animal model of hepatic ischemia/reperfusion injury

  2019cites this paper
• Steap 3 deficiency in hepatocytes protects the liver against ischemia / reperfusion injury by suppressing TAK 1

  2019influential citation
• The effects of hepatic ischemia/reperfusion injury on postoperative cognitive function in aged rats

  2019cites this paper
• Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction

  2018cites this paper
• SIRT6 protects against hepatic ischemia/reperfusion injury by inhibiting apoptosis and autophagy related cell death

  2018cites this paper
• Lactobacillus plantarum reverse diabetes-induced Fmo3 and ICAM expression in mice through enteric dysbiosis-related c-Jun NH2-terminal kinase pathways

  2018cites this paper
• Dual Effect of Hepatic Macrophages on Liver Ischemia and Reperfusion Injury during Liver Transplantation

  2018cites this paper
• Tauroursodeoxycholic acid alleviates hepatic ischemia reperfusion injury by suppressing the function of Kupffer cells in mice.

  2018cites this paper
• New therapeutic strategy of hinokitiol in haemorrhagic shock‐induced liver injury

  2018cites this paper
• Cholecystokinin protects mouse liver against ischemia and reperfusion injury

  2017cites this paper
• The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury

  2017cites this paper
• NF-κB and Its Implication in Liver Health and Cancer Development

  2017cites this paper
• STAT6 silencing induces hepatocellular carcinoma-derived cell apoptosis and growth inhibition by decreasing the RANKL expression.

  2017cites this paper
• Severe hepatocytotoxicity linked to denosumab.

  2017cites this paper
• Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation

  2017cites this paper
• Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury.

  2016cites this paper
• Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.

  2016cites this paper
• Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.

  2016cites this paper
• Fatty acid binding protein-4 ( FABP 4 ) is a hypoxia inducible gene that sensitizes mice to liver ischemia / reperfusion injury

  2016cites this paper
• Obesity and Glucose Metabolism

  2015cites this paper
• The mechanisms and strategies to protect from hepatic ischemia-reperfusion injury.

  2015cites this paper
• Diabetic Retinopathy: Vascular and Inflammatory Disease

  2015cites this paper
• Chinese Herbal Preparation Xuebijing Potently Inhibits Inflammasome Activation in Hepatocytes and Ameliorates Mouse Liver Ischemia-Reperfusion Injury

  2015cites this paper
• Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia/reperfusion injury.

  2015cites this paper
• Ginsenoside Rg1, a potential JNK inhibitor, protects against ischemia/reperfusion-induced liver damage

  2015cites this paper
• The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes

  2014cites this paper
• Butyrate protects liver against ischemia reperfusion injury by inhibiting nuclear factor kappa B activation in Kupffer cells.

  2014cites this paper
• Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms.

  2014cites this paper
• Sirtuin 1-Mediated Inhibition of p66shc Expression Alleviates Liver Ischemia/Reperfusion Injury

  2014cites this paper
• Activation of the receptor activator of the nuclear factor-κB ligand pathway during coronary bypass surgery: comparison between on- and off-pump coronary artery bypass surgery procedures.

  2013cites this paper
• Hepatic ischemia-reperfusion increases circulating bone marrow-derived progenitor cells and tumor growth in a mouse model of colorectal liver metastases.

  2013cites this paper
• Editorial comment: The end of all our exploring ...

  2013cites this paper
• Commentary on: Age-related differences in hepatic ischemia/reperfusion: gene activation, liver injury, and protective effect of melatonin.

  2013cites this paper
• PPARs and Liver Disease

  2013cites this paper
• PPARs and Liver Disease

  2013cites this paper
• Hepatic Ischemia and Reperfusion Injury and Trauma: Current Concepts

  2013cites this paper
• Antioxidant Stress and Anti-Inflammation of PPARα on Warm Hepatic Ischemia-Reperfusion Injury

  2012cites this paper
• Use of a Hanging-weight System for Liver Ischemia in Mice

  2012cites this paper